Synopsis
Synopsis
0
JDMF
0
VMF
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cefuroxime
2. Cephuroxime
3. Ketocef
4. Zinacef
1. Sodium Cefuroxime
2. Zinacef
3. Cefuroxime Sodium Salt
4. Biociclin
5. 56238-63-2
6. Anaptivan
7. Kefurox
8. Cefuroxime (sodium)
9. Cefumax
10. Cefurex
11. Medoxim
12. Kesint
13. Chebi:3517
14. R8a7m9my61
15. Colifossim
16. Sodium (6r,7r)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(z)-(o-methyloxime), Carbamate (ester)
17. Spectrazolr
18. Bioxima
19. Cefofix
20. Curoxim
21. Curoxima
22. Curoxime
23. Furoxil
24. Ketocef
25. Ultroxim
26. Cefuroxim Hexal
27. Cefuroxim Lilly
28. Cefuroxima Fabra
29. Cefuroxim Aj
30. Cefuroxim Mn
31. Cefuroxim Curasan
32. Cefuroxima Richet
33. Cetroxil [inj.]
34. Cefuroxim Fresenius
35. Cefuroxim Genericsn
36. Froxal [inj.]
37. Sharox [inj.]
38. Zinnat [inj.]
39. Cetroxil
40. Froxal
41. Cefuroxim Norcox
42. Cefuroxim Norcox [inj.]
43. Cefuroxime Na
44. Kefurox In Plastic Container
45. Zinacef In Plastic Container
46. Zinacef (tn)
47. Einecs 260-073-1
48. Cefuroxime And Dextrose In Duplex Container
49. Unii-r8a7m9my61
50. Mls000069576
51. Cefuroxime Sodium [usp:ban:jan]
52. Cefuroxime For Injection And Dextrose For Injection In Duplex Container
53. Sodium;(6r,7r)-3-(carbamoyloxymethyl)-7-[[(2z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
54. Ks-1040
55. Smr000058808
56. Mls001332625
57. Mls001332626
58. Sodium (6r-(6alpha,7beta(z)))-3-(((aminocarbonyl)oxy)methyl)-7-(2-furyl(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
59. Cefuroxime Sodium (jan/usp)
60. Schembl719536
61. Cefuroxime Sodium [jan]
62. Chembl2146124
63. Cefuroxime Sodium [vandf]
64. Cefuroxime Sodium [mart.]
65. Dtxsid201015616
66. Hms2097o21
67. Hms3714o21
68. Cefuroxime Sodium [usp-rs]
69. Cefuroxime Sodium [who-dd]
70. Cefuroxime Sodium Salt [mi]
71. Hy-b1256
72. Mfcd09878727
73. S4620
74. Akos015961772
75. Ccg-220720
76. Cefuroxime Sodium [ep Impurity]
77. Cefuroxime Sodium [orange Book]
78. Cs-4733
79. Nsc 758166
80. Cefuroxime Sodium [ep Monograph]
81. Cefuroxime Sodium [usp Impurity]
82. Cefuroxime Sodium [usp Monograph]
83. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt (6r-(6alpha,7beta(z)))-
84. Ac-15028
85. C08108
86. D00915
87. Cefuroxime Sodium 100 Microg/ml In Acetonitrile/water
88. Cefuroxime Sodium 100 Microg/ml In Acetonitrile:water
89. Cefuroxime Sodium, European Pharmacopoeia (ep) Reference Standard
90. Cefuroxime Sodium, United States Pharmacopeia (usp) Reference Standard
91. (6r,7r)-3-(carbamoyloxymethyl)-7-[[(2z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
92. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt (6r-(6.alpha.,7.beta.(z)))-
93. Sodium (6r,7r)-3-(carbamoyloxymethyl)-7-((e)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Molecular Weight | 446.4 g/mol |
---|---|
Molecular Formula | C16H15N4NaO8S |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 8 |
Exact Mass | 446.05082891 g/mol |
Monoisotopic Mass | 446.05082891 g/mol |
Topological Polar Surface Area | 202 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 804 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Cefuroxime and dextrose in duplex container |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 750mg base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | B Braun |
2 of 6 | |
---|---|
Drug Name | Cefuroxime sodium |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Intramuscular, intravenous; Im-iv; Injection |
Strength | eq 750mg base/vial; eq 7.5gm base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | Teva Pharms; Hospira; Steri Pharma; Hikma Farmaceutica |
3 of 6 | |
---|---|
Drug Name | Zinacef in plastic container |
Drug Label | Cefuroxime is a sterile semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration. It is the sodium salt of (6R, 7R)-3-carbamoyloxymethyl-7-[Z-2-methoxyimino-2-(fur-2-yl)acetamido]ceph-3-em-4-carboxylate, and it has the fo... |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 30mg base/ml |
Market Status | Prescription |
Company | Covis Injectables |
4 of 6 | |
---|---|
Drug Name | Cefuroxime and dextrose in duplex container |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 750mg base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | B Braun |
5 of 6 | |
---|---|
Drug Name | Cefuroxime sodium |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Intramuscular, intravenous; Im-iv; Injection |
Strength | eq 750mg base/vial; eq 7.5gm base/vial; eq 1.5gm base/vial |
Market Status | Prescription |
Company | Teva Pharms; Hospira; Steri Pharma; Hikma Farmaceutica |
6 of 6 | |
---|---|
Drug Name | Zinacef in plastic container |
Drug Label | Cefuroxime is a sterile semisynthetic, broad-spectrum, cephalosporin antibiotic for parenteral administration. It is the sodium salt of (6R, 7R)-3-carbamoyloxymethyl-7-[Z-2-methoxyimino-2-(fur-2-yl)acetamido]ceph-3-em-4-carboxylate, and it has the fo... |
Active Ingredient | Cefuroxime sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 30mg base/ml |
Market Status | Prescription |
Company | Covis Injectables |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?